ArticlePathologie (Heidelberg, Germany)2026
[From autopsy to translatability].
Article in Pathologie (Heidelberg, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAlthough autopsy techniques have remained virtually unchanged for almost 150 years, the scientific potential of biomaterials and data from autopsies has evolved significantly due to advances in analytical methods, imaging techniques, and computer-assisted analysis. MATERIALS AND
methodsNative and contrast-enhanced postmortem imaging techniques were established and evaluated in clinical autopsies. Contrast-enhanced postmortem imaging was used as a translational tool to quantify renal vascular density in chronic kidney disease. The value of biomaterials from clinical autopsies for translational research was investigated. The establishment of a national autopsy registry enabled comprehensive analyses of data obtained from autopsies.
resultsThe development, application, and evaluation of native and contrast-enhanced postmortem imaging techniques; the translational use of postmortem imaging; and the application of various molecular biological methods to biomaterials obtained from autopsies, as well as the collection and systematic analysis of data from autopsies, each showed unique potential. This is not only applicable to further development of postmortem diagnostics, but also to translational research.
conclusionsPostmortem biomaterials and data are unique for many scientific questions, for example in multisystem diseases and complex disease progression. It is therefore crucial that we, as a pathology community, use and further develop innovative methods in the field of autopsy.
Indexed as
Identifiers
41307686What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.